MARKET

LCTX

LCTX

Lineage Cell The
AMEX
1.675
+0.035
+2.13%
Opening 11:24 04/17 EDT
OPEN
1.650
PREV CLOSE
1.640
HIGH
1.685
LOW
1.640
VOLUME
336.86K
TURNOVER
--
52 WEEK HIGH
2.090
52 WEEK LOW
0.4000
MARKET CAP
417.22M
P/E (TTM)
-6.0666
1D
5D
1M
3M
1Y
5Y
1D
Lineage Cell Therapeutics announces formation of Scientific Advisory Board
TipRanks · 4d ago
Weekly Report: what happened at LCTX last week (0406-0410)?
Weekly Report · 4d ago
Lineage Cell Therapeutics management to meet with Craig-Hallum
TipRanks · 04/08 20:56
Service Properties Trust, ConocoPhillips And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Benzinga · 04/06 12:03
Weekly Report: what happened at LCTX last week (0330-0403)?
Weekly Report · 04/06 09:47
Weekly Report: what happened at LCTX last week (0323-0327)?
Weekly Report · 03/30 09:47
Lineage Cell Therapeutics Is Maintained at Buy by B. Riley Securities
Dow Jones · 03/25 15:23
Lineage Cell Therapeutics Price Target Raised to $4.00/Share From $3.00 by B. Riley Securities
Dow Jones · 03/25 15:23
More
About LCTX
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing cell replacement therapies to treat serious medical conditions. The Company programs are based on a cell-based technology platform, AlloSCOPE, which develops formulation, manufacturing, and delivery capabilities, and serves as the source of its pluripotent cell-based product candidates. Its pipeline includes OpRegen, an allogeneic retinal pigment epithelial (RPE) cell replacement therapy for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (dry-AMD); OPC1, an allogeneic oligodendrocyte progenitor cell therapy for the treatment of spinal cord injuries (SCI); ReSonance (ANP1), an allogeneic auditory neuron progenitor cell transplant therapy for the treatment of auditory neuropathy; ILT1, an allogeneic cell transplant research initiative for the treatment of Type 1 Diabetes (T1D).

Webull offers Lineage Cell Therapeutics Inc stock information, including AMEX: LCTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LCTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LCTX stock methods without spending real money on the virtual paper trading platform.